Erythropoietin treatment and the risk of hip fractures in hemodialysis patients

This study implicates EPO treatment as an independent ri sk factor for hip fractures in hemodialysis patients and supports the conclusion that EPO treatment may have contributed to changing trends in fracture incidence for these patients during recent decades. © 2021 American Society for Bone and Mineral Research (ASBMR).
Source: Journal of Bone and Mineral Research - Category: Orthopaedics Authors: Tags: Original Article Source Type: research